Singapore, Singapore, January 8th, 2026, FinanceWireLiminal, a leading digital asset infrastructure company, today announced ...
EY sets out four regulatory priorities that will impact UK financial services in 2026 and how firms should react ...
Prudential Financial's investment arm, PGIM Inc., is reportedly contemplating the sale of its underperforming Indian asset management unit, PGIM India Asset Management Pvt Ltd.
New analysis from the Big Four accounting firm indicates that the IPO market finished on a stronger footing after a rebound ...
On investment priorities, EY said the government should consider expanding the Production-Linked Incentive (PLI) scheme to ...
Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...
Gold hits record and oil rises and Iran tensions; household spending above expectations; Domino’s shares jump on new ...
A cable company in Erith has gone into administration after seven decades in business. Established in the 1950s, Erith-based ...
Ernst & Young Solutions (EY) has released its wishlist ahead of Singapore Budget 2026, which will be presented on Feb 12. In ...
The audit of Shell, one of the most lucrative on the FTSE 100, has been carried out by EY for almost a decade. The firm was paid $66mn for its work for the energy major in 2024 and $264mn over the ...
One of Australia’s richest families has launched explosive legal action seeking close to $50m in damages from two major ...
Vietnam Investment Review on MSN
Chipscreen Biosciences founder wins EY Entrepreneur Of The Year 2025
Dr. Lu Xianping was recognised for his leadership in innovative drug development and building a successful biopharma company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results